Article
Peptide-MHC-targeted retroviruses enable <i>in vivo</i> expansion and gene delivery to tumor-specific T cells
2024-09-22
Abstract excerpt
Tumor-infiltrating-lymphocyte (TIL) therapy has demonstrated that endogenous T cells can be harnessed to initiate an effective anti-tumor response. Despite clinical promise, current TIL production protocols involve weeks-long ex vivo expansions which can affect treatment efficacy. Therefore, additional tools are needed to engineer endogenous tumor-specific T cells to have increased potency while mitigating challe...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 3dcae8bc-1824-5039-8ac1-3be73ee6ba5d
- DOI
- 10.1101/2024.09.18.613594
